KI, OUH, Research unit of Clinical Immunology (Odense)

Medicine & Life Sciences

1. Blood Donors 100%
2. Denmark 93%
3. SARS Virus 59%
4. Antibodies 53%
5. Cohort Studies 44%
6. Immunoglobulin G 43%
7. Celiac Disease 38%
8. Haemophilus influenzae type b 36%
9. T-Lymphocytes 36%
10. Neuromyelitis Optica 35%
11. Population 33%
12. Tissue Donors 33%
13. Coronavirus 31%
14. Vaccination 30%
15. Infections 30%
16. Severe Acute Respiratory Syndrome 29%
17. Polysaccharides 26%
18. Rheumatoid Arthritis 26%
19. Antibody-Producing Cells 26%
20. Blood Group Antigens 26%
21. B-Lymphocytes 26%
22. Child 25%
23. Blood Transfusion 25%
24. Optic Neuritis 23%
25. Genes 23%
26. Immunoglobulin A 22%
27. Conjugate Vaccines 22%
28. Vaccines 21%
29. Confidence Intervals 21%
30. Immunoglobulin M 20%
31. Multiple Sclerosis 20%
32. microfibrillar protein 20%
33. Biomarkers 20%
34. Chimeric Antigen Receptors 19%
35. Antibody Formation 18%
36. Therapeutics 17%
37. Chimerism 17%
38. Twin Studies 17%
39. Hepatitis B 16%
40. Seroepidemiologic Studies 16%
41. Serum 16%
42. Fecal Microbiota Transplantation 16%
43. Mutation 16%
44. Aquaporin 4 16%
45. Erythrocytes 15%
46. Blood Platelets 15%
47. Cross-Sectional Studies 15%
48. Pandemics 15%
49. Alleles 15%
50. Prospective Studies 15%
51. Pregnancy 14%
52. Iron 14%
53. Antigens 14%
54. Autoantibodies 14%
55. Incidence 14%
56. Enzyme-Linked Immunosorbent Assay 14%
57. Multiple Myeloma 13%
58. Mothers 13%
59. Virus Diseases 13%
60. Coronavirus Infections 13%
61. Registries 13%
62. Hepatitis C 13%
63. Platelet Aggregation 13%
64. Pregnant Women 13%
65. Blood Safety 13%
66. Cerebrospinal Fluid 13%
67. Parvovirus 12%
68. Hepacivirus 12%
69. Phenotype 12%
70. Epidemiology 12%
71. Tetanus Toxoid 12%
72. Twins 11%
73. Human Parvovirus B19 11%
74. In Vitro Techniques 11%
75. Odds Ratio 11%
76. Messenger RNA 11%
77. RHO(D) antibody 11%
78. Encephalitis 11%
79. Hemorrhage 11%
80. Biopsy 11%
81. Chronic Hepatitis C 10%
82. HLA Antigens 10%
83. Mortality 10%
84. Systematic Reviews 10%
85. Exons 10%
86. Meta-Analysis 10%
87. Erythema Infectiosum 10%
88. HLA-A Antigens 10%
89. Randomized Controlled Trials 10%
90. Transplants 10%
91. Anti-Citrullinated Protein Antibodies 10%
92. Neoplasms 10%
93. Familial Mediterranean Fever 10%
94. Sweden 10%
95. Stem Cells 10%
96. Hidradenitis Suppurativa 10%
97. anti-IgG 10%
98. Hereditary Angioedemas 9%
99. Hepatitis E 9%
100. Diphtheria Toxoid 9%